Medtronic stock: buy or sell?
August 19th, 2019
Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Should I buy Medtronic stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, 2 buy setups are elegible for Medtronic stock now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Medtronic stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we collected 15 ratings published for MDT stock in the last 30 days. The general sentiment of these ratings is bullish for MDT stock, with 7 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-16||Royal Bank of Canada||n/a||Outperform|
|2019-8-14||Morgan Stanley||n/a||Equal Weight|
|2019-7-23||Needham & Company LLC||n/a||Buy|
|2019-4-4||Wells Fargo & Co||Market Perform||Market Perform|
|2019-2-4||Needham & Company LLC||Strong-Buy||Strong-Buy|
|2019-2-4||Needham & Company LLC||n/a||Strong-Buy|
|2019-1-2||Morgan Stanley||Equal Weight||Equal Weight|
Medtronic stock analysis
Medtronic inched 1.38% to $104.18 after reaching all time highs yesterday.
Medtronic inched 1.38% yesterday and reached a new all time high at $104.43. On July, SMA100d and SMA200d crossed up triggering a rise of 7.56%. Since last May when MDT stock price broke up the SMA200d line, it gained $15.91 (18.02%).
Shares of Medtronic closed this week at $104.18 after topping to a new all time high ($104.43) and raised a slightly good 1.38%.
MDT shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom early August, MDT climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up late June, MDT price climbed $5.34 per share (5.40%). Since late May when MDT stock price broke up the SMA40w line, it gained $16.93 (19.40%).
Medtronic stock price history
Medtronic stock historical price chart
MDT stock reached all-time highs yesterday with a price of $104.43.
Medtronic stock price target is $105.60Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we found 14 price forecasts for Medtronic stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-16||Royal Bank of Canada||Raises Target||n/a||$110.00||-|
|2019-8-14||Morgan Stanley||Raises Target||$100.00||$105.00||5%|
|2019-6-14||UBS Group||Raises Target||n/a||$112.00||-|
|2019-4-4||Wells Fargo & Co||Lowers Target||$101.00||$100.00||-1%|
|2019-2-4||Needham & Company LLC||Reiterates||$120.00||$117.00||-2.5%|
|2019-2-4||Needham & Company LLC||Lowers Target||$120.00||$117.00||-2.5%|
|2019-1-2||Morgan Stanley||Raises Target||$98.00||$102.00||4.1%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Medtronic presented its financial report, posting a tiny climb for the Earnings per Share (EPS) ratio. Analyst were expecting $1.24 per share, but Medtronic posted $1.29.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Medtronic annual sales stayed constant a tight 0.01% to $29,953.00 million USD from $29,950.00 marked in 2018. Aligned with this, its income margin (compared to sales) remained stable to 10.36%, that is $3,104.00 million. To have an updated picture of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M dollars. If we compare this TTM figures with the last reported annuality, we can review Medtronic business evolution since April 2018: Annual sales up to January, compared to lastest yearly report, grew a tiny 2.01%. In line, profit margin (net income/sales) escalated at 10.36%.
|2014||$17,010 M||-||$3,070 M18.0%||-|
|2014||$17,010 M||0.00%||$3,070 M18.0%||0.00%|
|2015||$20,260 M||19.11%||$2,680 M13.2%||-12.70%|
|2015||$20,261 M||0.00%||$2,675 M13.2%||-0.19%|
|2016||$28,830 M||42.29%||$3,540 M12.3%||32.34%|
|2016||$28,833 M||0.01%||$3,538 M12.3%||-0.06%|
|2017||$29,710 M||3.04%||$4,030 M13.6%||13.91%|
|2017||$29,710 M||0.00%||$4,028 M13.6%||-0.05%|
|2018||$29,950 M||0.81%||$3,100 M10.4%||-23.04%|
|2018||$29,953 M||0.01%||$3,104 M10.4%||0.13%|
|TTM||$30,555 M||2.01%||$4,919 M16.1%||58.47%|
Quarterly financial resultsMedtronic reported $7,546.00 M in revenues for 2019-Q1, a 0.87% improvement compared to previous quarter. Reported quarter income marked $1,269.00 M with a profit margin of 16.82%. Profit margin stepped up a 1.91% compared to previous quarter when profit margin was 14.90%. When comparing sales to same quarter last year, Medtronic sales marked a slightly fine growth and raised a 2.40%. Looking back to recent quarterly results, Medtronic posted 2 negative quarters in a row.
|2017-Q2||$7,920 M||-||$1,160 M14.6%||-|
|2017-Q3||$7,390 M||-6.69%||$1,020 M13.8%||-12.07%|
|2017-Q4||$7,050 M||-4.60%||$2,017 M28.6%||97.75%|
|2018-Q1||$7,369 M||4.52%||$-1,389 M-18.8%||-168.86%|
|2018-Q2||$8,144 M||10.52%||$1,460 M17.9%||-205.11%|
|2018-Q3||$7,384 M||-9.33%||$1,075 M14.6%||-26.37%|
|2018-Q4||$7,481 M||1.31%||$1,115 M14.9%||3.72%|
|2019-Q1||$7,546 M||0.87%||$1,269 M16.8%||13.81%|
Medtronic ownershipWhen you are planning to buy a stock, it's worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.
Bearish positions for MDT stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related companies:
|Market cap||$0.0 M||$150.6 B||$44.8 B||$59.4 B||$2.7 B|
|Total shares||0.0 M||1,760.0 M||510.2 M||1,390.0 M||28.3 M|
|Float shares||1,340.0 M||1,750.0 M||509.5 M||1,390.0 M||27.6 M|
|- Institutional holdings (%)||84.2%||76.5%||88.2%||93.4%||97.5%|
|- Insider holdings (%)||0.1%||0.7%||0.1%||0.2%||1.8%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Monday, August 19th, 2019|
|Day range||$103.02 - $104.43|
|Average true range||$2.01|
|50d mov avg||$99.88|
|100d mov avg||$94.32|
|200d mov avg||$92.00|
Medtronic performanceTo measure stock performance is always good to compare with competitors or related stocks. We compared Medtronic against , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet in the following table:
|OMIOwens & Minor||42.53%||-22.14%||-69.40%|
Medtronic competitorsOne check before trading any stock is to review a list of its competitors, in this case for Medtronic. We picked 10 companies as Medtronic competitors as they are in the same industry or have similar market objectives.
- Baxter International (BAX)
- Boston Scientific (BSX)
- CONMED (CNMD)
- Edwards Lifesciences (EW)
- Integra LifeSciences (IART)
- Owens & Minor (OMI)
- Stryker (SYK)
- Zimmer Biomet (ZBH)
Latest Medtronic stock news
- InvestorPlace3 Big Stock Charts for Monday: Medtronic, Paychex and AbbVieJune 24, 2019
- InvestorPlace3 Big Stock Charts for Friday: Medtronic, LKQ and Lamb WestonMarch 15, 2019
- InvestorPlaceMedtronic Earnings: MDT Reports Q3 Earnings BeatFebruary 19, 2019
- InvestorPlace3 Big Stock Charts for Tuesday: Microsoft, Medtronic and Intercontinental ExchangeJanuary 8, 2019
- InvestorPlace3 Big Stock Charts for Thursday: Medtronic, Facebook and eBayJanuary 3, 2019